New drug duo tested to fight back against rare liver disease
Disease control
Completed
This study tested whether adding a new drug called bezafibrate to an existing one (obeticholic acid) could better control Primary Biliary Changitis (PBC), a chronic liver disease. It involved 72 adults with PBC who were already on standard treatment. The main goal was to see if t…
Phase: PHASE2 • Sponsor: Intercept Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC